XPO1 inhibition by selinexor induces potent cytotoxicity against high grade bladder malignancies

Treatment options for high grade urothelial cancers are limited and have remained largely unchanged for several decades. Selinexor (KPT-330), a first in class small molecule that inhibits the nuclear export protein XPO1, has shown efficacy as a single agent treatment for numerous different malignanc...

Descripción completa

Detalles Bibliográficos
Autores principales: Baek, Han Bit, Lombard, Alan P., Libertini, Stephen J., Fernandez-Rubio, Aleida, Vinall, Ruth, Gandour-Edwards, Regina, Nakagawa, Rachel, Vidallo, Kathleen, Nishida, Kristine, Siddiqui, Salma, Wettersten, Hiromi, Landesman, Yosef, Weiss, Robert H., Ghosh, Paramita M., Mudryj, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6195388/
https://www.ncbi.nlm.nih.gov/pubmed/30349650
http://dx.doi.org/10.18632/oncotarget.26179

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6195388/
https://www.ncbi.nlm.nih.gov/pubmed/30349650
http://dx.doi.org/10.18632/oncotarget.26179

Ejemplares similares